Literature DB >> 5351127

Metabolism of 14C-imipramine. II. Urinary metabolites in man.

J L Crammer, B Scott, B Rolfe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5351127     DOI: 10.1007/bf00411170

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  12 in total

1.  Plasma concentrations of tricyclic antidepressive drugs.

Authors:  M Lader
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

2.  Metabolic interaction between imipramine and carbamazepine in vivo and in vitro in rats.

Authors:  W Daniel; K J Netter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

3.  Formation of N-glucuronide of desmethylimipramine in the dog.

Authors:  M H Bickel; R Minder; C Di Francesco
Journal:  Experientia       Date:  1973-08-15

4.  Antidepressants and tranquillizers: biochemical aspects.

Authors:  M H Bickel
Journal:  Humangenetik       Date:  1970

5.  Drug plasma levels and clinical effect.

Authors:  J L Crammer
Journal:  Proc R Soc Med       Date:  1971-03

6.  Plasma levels of imipramine and desipramine in man after different routes of administration.

Authors:  A Nagy; R Johansson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

7.  Separation and quantitative determination of imipramine and desipramine from rat biological samples by high pressure liquid chromatography.

Authors:  A Bonora; P A Borea
Journal:  Experientia       Date:  1978-11-15

8.  Desipramine pharmacokinetics in Chinese and Caucasian volunteers.

Authors:  M V Rudorfer; E A Lane; W H Chang; M D Zhang; W Z Potter
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

9.  Pharmacokinetics of nomifensine in impaired renal function.

Authors:  S Ringoir; N Lameire; M Munche; W Heptner; K Taeuber
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of drugs used to treat urge incontinence.

Authors:  David R P Guay
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.